Letrozole -2.5mg/50count
Letrozole is a non-steroidal aromatase inhibitor researched for its ability to reduce estrogen synthesis by inhibiting the aromatase enzyme. Researchers commonly investigate its effects on hormone regulation and endocrine system balance. Letrozole has been studied in applications involving estrogen-sensitive pathways and hormonal optimization. Its potent aromatase inhibition makes it a frequently researched compound in endocrine science.
Letrozole, also known by its brand name Femara, is a medication primarily used to treat hormone receptor-positive breast cancer in postmenopausal women. Here are some key benefits:
-
Reduces Estrogen Levels: Letrozole works by inhibiting the enzyme aromatase, which converts androgens into estrogens. Lowering estrogen levels helps slow or stop the growth of certain types of breast cancer1.
-
Prevents Cancer Recurrence: Studies have shown that letrozole can reduce the risk of breast cancer recurrence more effectively than other treatments like tamoxifen.
-
Improves Survival Rates: Women treated with letrozole have shown improved survival rates compared to those treated with other medications.
-
Off-Label Use for Fertility: Letrozole is sometimes used off-label to induce ovulation in women with polycystic ovary syndrome (PCOS), increasing the chances of pregnancy.
-
Oral Administration: It is taken orally, making it a convenient and non-invasive treatment option
